Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceutical Distribution			5.27B	5.28B	5.36B	4.86B	5.64B
Pharmaceutical Distribution Growth			-0.10%	-1.53%	10.44%	-13.97%	33.60%
Medical Services			1.79B	1.86B	2.07B	1.97B	1.94B
Medical Services Growth			-3.90%	-10.18%	5.24%	1.27%	24.94%
Pharmaceutical Manufacturing			843.52M	790.26M	704.12M	606.74M	834.34M
Pharmaceutical Manufacturing Growth			6.74%	12.23%	16.05%	-27.28%	7.65%
Other Industries			2.30M	8.61M	14.29M	18.15M	35.30M
Other Industries Growth			-73.25%	-39.77%	-21.29%	-48.57%	38.68%
Consolidated Offset			-1.45B	-1.59B	-1.68B	-1.60B	-1.80B
Total			6.46B	6.35B	6.47B	5.85B	6.66B
Total Growth			1.75%	-1.88%	10.71%	-12.16%	1.14%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Northeast			23.28M	24.46M	30.22M	22.40M	28.36M
Northeast Growth			-4.83%	-19.05%	34.93%	-21.03%	-14.11%
North China			94.84M	104.62M	112.57M	89.81M	113.02M
North China Growth			-9.35%	-7.06%	25.34%	-20.54%	-0.47%
East China			606.83M	529.11M	398.71M	289.72M	284.01M
East China Growth			14.69%	32.71%	37.62%	2.01%	2.92%
South China			11.84M	14.72M	12.43M	34.37M	38.79M
South China Growth			-19.59%	18.40%	-63.83%	-11.38%	-17.14%
Central China			39.91M	39.66M	48.53M	42.44M	50.33M
Central China Growth			0.61%	-18.27%	14.36%	-15.69%	-11.85%
Northwest			7.06M	10.99M	12.13M	11.54M	12.99M
Northwest Growth			-35.79%	-9.39%	5.13%	-11.20%	-20.20%
Southwest			7.12B	7.22B	7.54B	6.92B	7.76B
Southwest Growth			-1.27%	-4.27%	8.90%	-10.82%	31.11%
Consolidated Offset			-1.45B	-1.59B	-1.68B	-1.60B	-1.80B
Overseas			-	-	-	36.63M	167.70M
Overseas Growth			-	-	-	-78.16%	42.68%
Total			6.46B	6.35B	6.47B	5.85B	6.66B
Total Growth			1.75%	-1.88%	10.71%	-12.16%	1.14%

Source: S&P Global Market Intelligence.